A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
Public ClinicalTrials.gov record NCT02260791. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Study identification
- NCT ID
- NCT02260791
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Fujifilm Kyowa Kirin Biologics Co., Ltd.
- Industry
- Enrollment
- 728 participants
Conditions and interventions
Conditions
Interventions
- FKB327 Drug
- Humira® Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2014
- Primary completion
- Jun 30, 2016
- Completion
- Jun 30, 2016
- Last update posted
- Nov 27, 2017
2014 – 2016
United States locations
- U.S. sites
- 16
- U.S. states
- 9
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Peoria | Arizona | — | — |
| Research Site | Palm Desert | California | — | — |
| Research Site | Boca Raton | Florida | — | — |
| Research Site | Brandon | Florida | — | — |
| Research Site | Jacksonville | Florida | — | — |
| Research Site | Miami | Florida | — | — |
| Research Site | Miami Lakes | Florida | — | — |
| Research Site | Sarasota | Florida | — | — |
| Research Site | Shreveport | Louisiana | — | — |
| Research Site | Lansing | Michigan | — | — |
| Research Site | Durham | North Carolina | — | — |
| Research Site | Middleburg Heights | Ohio | — | — |
| Research Site | Duncansville | Pennsylvania | — | — |
| Research Site | Amarillo | Texas | — | — |
| Research Site | Austin | Texas | — | — |
| Research Site | Mesquite | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 84 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02260791, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 27, 2017 · Synced May 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02260791 live on ClinicalTrials.gov.